Cargando…
Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834008/ https://www.ncbi.nlm.nih.gov/pubmed/33232829 http://dx.doi.org/10.1016/j.anai.2020.11.009 |
| _version_ | 1783642189286342656 |
|---|---|
| author | Manian, Deepti Vellaichamy Jensen, Chelsee Theel, Elitza S. Mills, John R. Joshi, Avni |
| author_facet | Manian, Deepti Vellaichamy Jensen, Chelsee Theel, Elitza S. Mills, John R. Joshi, Avni |
| author_sort | Manian, Deepti Vellaichamy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7834008 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78340082021-01-26 Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products Manian, Deepti Vellaichamy Jensen, Chelsee Theel, Elitza S. Mills, John R. Joshi, Avni Ann Allergy Asthma Immunol Letter American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021-02 2020-11-21 /pmc/articles/PMC7834008/ /pubmed/33232829 http://dx.doi.org/10.1016/j.anai.2020.11.009 Text en © 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Manian, Deepti Vellaichamy Jensen, Chelsee Theel, Elitza S. Mills, John R. Joshi, Avni Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products |
| title | Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products |
| title_full | Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products |
| title_fullStr | Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products |
| title_full_unstemmed | Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products |
| title_short | Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products |
| title_sort | non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834008/ https://www.ncbi.nlm.nih.gov/pubmed/33232829 http://dx.doi.org/10.1016/j.anai.2020.11.009 |
| work_keys_str_mv | AT maniandeeptivellaichamy nonneutralizingantibodiesandlimitationsofserologictestingforsevereacuterespiratorysyndromecoronavirus2inpatientsreceivingimmunoglobulinreplacementproducts AT jensenchelsee nonneutralizingantibodiesandlimitationsofserologictestingforsevereacuterespiratorysyndromecoronavirus2inpatientsreceivingimmunoglobulinreplacementproducts AT theelelitzas nonneutralizingantibodiesandlimitationsofserologictestingforsevereacuterespiratorysyndromecoronavirus2inpatientsreceivingimmunoglobulinreplacementproducts AT millsjohnr nonneutralizingantibodiesandlimitationsofserologictestingforsevereacuterespiratorysyndromecoronavirus2inpatientsreceivingimmunoglobulinreplacementproducts AT joshiavni nonneutralizingantibodiesandlimitationsofserologictestingforsevereacuterespiratorysyndromecoronavirus2inpatientsreceivingimmunoglobulinreplacementproducts |